Takahashi S - Search Results

1

Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line.

Nakano K, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Tomomatsu J, Ono M, Taira S, Nishizawa M, Wang X, Ohmoto A, Sato Y, Fukuda N, Urasaki T, Takahashi S. Nakano K, et al. Among authors: takahashi s. Mol Clin Oncol. 2021 Jan;14(1):13. doi: 10.3892/mco.2020.2175. Epub 2020 Nov 25. Mol Clin Oncol. 2021. PMID: 33282288 Free PMC article.

2

Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer.

Yuasa T, Urakami S, Yamamoto S, Yonese J, Nakano K, Kodaira M, Takahashi S, Hatake K, Inamura K, Ishikwa Y, Fukui I. Yuasa T, et al. Among authors: takahashi s. Urology. 2011 Apr;77(4):831-5. doi: 10.1016/j.urology.2010.12.008. Epub 2011 Feb 12. Urology. 2011. PMID: 21316083

3

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.

Tokudome N, Ito Y, Takahashi S, Kobayashi K, Taira S, Tsutsumi C, Oto M, Oba M, Inoue K, Kuwayama A, Masumura K, Nakayama Y, Watanabe C, Hatake K. Tokudome N, et al. Among authors: takahashi s. Breast Cancer. 2011 Jul;18(3):195-202. doi: 10.1007/s12282-011-0259-4. Epub 2011 Apr 5. Breast Cancer. 2011. PMID: 21465230 Clinical Trial.

4

Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib.

Yuasa T, Tsuchiya N, Urakami S, Horikawa Y, Narita S, Inoue T, Saito M, Yamamoto S, Yonese J, Fukui I, Nakano K, Takahashi S, Hatake K, Habuchi T. Yuasa T, et al. Among authors: takahashi s. BJU Int. 2012 May;109(9):1349-54. doi: 10.1111/j.1464-410X.2011.10534.x. Epub 2011 Aug 25. BJU Int. 2012. PMID: 21883864

5

High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone.

Suzuki K, Terui Y, Nakano K, Nara E, Nasu K, Ueda K, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Takahashi S, Hatake K. Suzuki K, et al. Among authors: takahashi s. Leuk Lymphoma. 2012 May;53(5):849-54. doi: 10.3109/10428194.2011.635858. Leuk Lymphoma. 2012. PMID: 22035416

6

Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas.

Nishimura N, Nakano K, Ueda K, Kodaira M, Yamada S, Mishima Y, Yokoyama M, Terui Y, Takahashi S, Hatake K. Nishimura N, et al. Among authors: takahashi s. Support Care Cancer. 2012 Sep;20(9):2053-9. doi: 10.1007/s00520-011-1314-6. Epub 2011 Nov 25. Support Care Cancer. 2012. PMID: 22116139

7

Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation study.

Ito Y, Suenaga M, Hatake K, Takahashi S, Yokoyama M, Onozawa Y, Yamazaki K, Hironaka S, Hashigami K, Hasegawa H, Takenaka N, Boku N. Ito Y, et al. Among authors: takahashi s. Jpn J Clin Oncol. 2012 Apr;42(4):278-86. doi: 10.1093/jjco/hys012. Epub 2012 Feb 27. Jpn J Clin Oncol. 2012. PMID: 22371427 Clinical Trial.

8

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

Nakano K, Takahashi S, Yuasa T, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Tsuyama N, Ishikawa Y, Hatake K. Nakano K, et al. Among authors: takahashi s. Jpn J Clin Oncol. 2012 Aug;42(8):697-703. doi: 10.1093/jjco/hys085. Epub 2012 Jun 13. Jpn J Clin Oncol. 2012. PMID: 22701038

9

Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.

Yasuda Y, Saito K, Yuasa T, Kitsukawa S, Urakami S, Yamamoto S, Yonese J, Takahashi S, Fukui I. Yasuda Y, et al. Among authors: takahashi s. Int J Clin Oncol. 2013 Oct;18(5):884-9. doi: 10.1007/s10147-012-0454-0. Epub 2012 Aug 11. Int J Clin Oncol. 2013. PMID: 22886358

10

Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma.

Yasuda Y, Fujii Y, Yuasa T, Kitsukawa S, Urakami S, Yamamoto S, Yonese J, Takahashi S, Fukui I. Yasuda Y, et al. Among authors: takahashi s. Int J Clin Oncol. 2013 Oct;18(5):877-83. doi: 10.1007/s10147-012-0472-y. Epub 2012 Sep 11. Int J Clin Oncol. 2013. PMID: 22965827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,152 results

Search Page